Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 3,788 | 2,482 | 2,817 | 2,474 |
| Operating Income | -3,788 | -2,482 | -2,817 | -2,474 |
| Interest Expense | 269 | 151 | N/A | N/A |
| Other Income | -16 | 20 | 26 | -3,047 |
| Pre-tax Income | -4,073 | -2,613 | -2,791 | -5,521 |
| Net Income Continuous | -4,073 | -2,613 | -2,791 | -5,521 |
| Net Income | $-4,073 | $-2,613 | $-2,791 | $-5,521 |
| EPS Basic Total Ops | -0.50 | -0.40 | -0.40 | -1.00 |
| EPS Basic Continuous Ops | -0.50 | -0.40 | -0.40 | -1.00 |
| EPS Diluted Total Ops | -0.50 | -0.40 | -0.40 | -1.00 |
| EPS Diluted Continuous Ops | -0.50 | -0.40 | -0.40 | -1.00 |
| EBITDA(a) | $-3,267 | $-1,926 | $-2,281 | $-2,062 |